Journey Medical Corporation (DERM) Financials

DERM Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 65.9 million 48.5 million
2023-06-30 69.7 million 69.7 million
2023-03-31 95.9 million 88.4 million
2022-12-31 105.2 million 88.2 million

DERM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 18.7 million 558000
2023-06-30 4.0 million 873000
2023-03-31 -6.0 million 646000
2022-12-31 -23.8 million 1.4 million

DERM Net Income

No data available :(

DERM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 24.7 million - 131000
2023-06-30 8.2 million - 154000
2023-03-31 17.3 million - 177000
2022-12-31 32.0 million - 191000

DERM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 18.5 million
2023-06-30 18.0 million
2023-03-31 17.8 million
2022-12-31 17.5 million

DERM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 2.2 million 8.6 million -
2023-06-30 - 1.8 million 12.1 million -
2023-03-31 5.0 million 2.0 million 13.3 million -
2022-12-31 20.0 million 4.3 million 14.0 million -

DERM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 34.5 million 6.4 million
2023-06-30 17.2 million 7.8 million
2023-03-31 12.2 million 6.4 million
2022-12-31 16.0 million 7.7 million

DERM

Price: $3.69

52 week price:
1.02
8.11

Earnings Per Share: -0.69 USD

P/E Ratio: -6.99

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 25200

Ebitda: -176.2 million

Market Capitalization: 83.3 million

Links: